May 15 (Reuters) - Incyte Corp INCY.O:
INCYTE ANNOUNCES FDA APPROVAL OF ZYNYZ® (RETIFANLIMAB-DLWR) MAKING IT THE FIRST AND ONLY APPROVED FIRST-LINE TREATMENT FOR ADVANCED ANAL CANCER PATIENTS IN THE UNITED STATES
Source text: ID:nBw2zJ9Tga
Further company coverage: INCY.O
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.